In contrast, cancers such as lower-grade glioma (LGG) and glioblastoma (GBM) demonstrated reduced median levels of CD8+ T cells and NK cells, alongside elevated M2 macrophage presence, correlating with poorer PFS (HR > 1) (208). Here, CD8A is linked to glioblastoma.